AIM
LLY icon

Acrospire Investment Management’s Eli Lilly LLY Stock Holding History

Acrospire Investment Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,399
Closed -$115K – 795
2017
Q2 		$115K Buy
1,399
+200
+17% +$16.3K 0.11% 171
2017
Q1 		$101K Sell
1,199
-900
-43% -$72.1K 0.08% 310
2016
Q4 		$154K Buy
2,099
+1,999
+1,999% +$149K 0.06% 581
2016
Q3 		$8K Buy
+100
New +$8K 0.01% 1749
2016
Q2 		– Sell
-300
Closed -$22K – 2158
2016
Q1 		$22K Buy
+300
New +$22.7K 0.02% 1493

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Acrospire Investment Management's LLY Position: Q3 2017 in Review

Acrospire Investment Management sold out of Eli Lilly (LLY) in Q3 2017, closing a stake of 1,399 shares — an estimated $115K sold.

Acrospire Investment Management first reported a position in LLY in Q1 2016 and held it in 5 quarters. The position peaked at $154K in Q4 2016. 1,228 funds tracked by Wall St. Rank hold LLY as of Q3 2017.

  • Acrospire Investment Management reported no remaining Eli Lilly position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 1,399 Eli Lilly shares in Q3 2017, an estimated $115K.
  • Acrospire Investment Management first reported a position in Eli Lilly in Q1 2016 and held it in 5 quarters.
  • Acrospire Investment Management's Eli Lilly position peaked at $154K in Q4 2016.
  • 1,228 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.